Invention Grant
- Patent Title: RAD51 inhibitors
-
Application No.: US16816393Application Date: 2020-03-12
-
Publication No.: US11247988B2Publication Date: 2022-02-15
- Inventor: Jean-Marc Lapierre , Casey Cameron McComas , Joseph Vacca
- Applicant: Cyteir Therapeutics, Inc.
- Applicant Address: US MA Lexington
- Assignee: Cyteir Therapeutics, Inc.
- Current Assignee: Cyteir Therapeutics, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Cooley LLP
- Agent Matthew Pavao; Chen Chen
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D417/12 ; C07D471/04 ; C07D277/30
Abstract:
This application is directed to inhibitors of RAD51 represented by the following structural formula, and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
Public/Granted literature
- US20200291014A1 RAD51 INHIBITORS Public/Granted day:2020-09-17
Information query
